Joseph Mosley, DO
Pain Medicine · Vineyard, UTNPI 1710331079
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 46.7% of the total. Reporting peaked in 2022 at $3,450 and has fallen 99.1% since, to $32 in 2025.
Across 100 payments — averaging $81.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$2K
- Relievant Medsystems, Inc.$1K
- Nevro Corp.$494
- SPR Therapeutics, Inc$71
- Averitas Pharma Inc.$54
- plus $145 from 8 others
What the payments were for
- Grants$1,57519%
- Travel & lodging$4,19951%
- Food & beverage$2,38629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 30 | $3,808 |
| Medtronic(2 entities) | 21 | $2,091 |
| Relievant Medsystems, Inc. | 23 | $1,497 |
| Nevro Corp. | 12 | $494 |
| SPR Therapeutics, Inc | 2 | $71 |
| Averitas Pharma Inc. | 2 | $54 |
| Merck | 2 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Nalu Medical, Inc. | 1 | $21 |
| Stimwave Technologies Incorporated | 2 | $19 |
| Painteq LLC | 1 | $18 |
| Chiesi USA, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $13 |
| Curonix LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,391
- Superion Indirect Decompression System$2,838
- SYNCHROMED$1,575
- Senza Spinal Cord Stimulation System$239
- SPECTRA WAVEWRITER$152
- RESTORE$124
- WAVEWRITER ALPHA$119
How this compares
$8,161 in reported general payments places this provider in the 80th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 17 | $5,345 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,527 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $1,510 |
| Gabapentin | 77 | $995 |
| Buprenorphine Hcl | 24 | $557 |
| Tizanidine Hcl | 50 | $451 |
| Pregabalin | 32 | $405 |
| Diclofenac Sodium | 28 | $401 |
| Celecoxib | 21 | $400 |
| Oxycodone Hcl | 24 | $340 |
| Methocarbamol | 20 | $289 |
| Cyclobenzaprine Hcl | 19 | $233 |
| Meloxicam | 26 | $114 |
| Tramadol Hcl | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Vineyard
- Braden JexVineyard$7K
- Eric FreemanVineyard$4K
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
- Derek HaightDraper$78K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.